MedPath
FDA Approval

Genvoya

January 13, 2022

HUMAN PRESCRIPTION DRUG LABEL

Elvitegravir(150 mg in 1 1)
Cobicistat(150 mg in 1 1)
Emtricitabine(200 mg in 1 1)
Tenofovir(10 mg in 1 1)

Products (1)

Genvoya

61958-1901

NDA207561

NDA (C73594)

ORAL

January 13, 2022

SODIUM LAURYL SULFATEInactive
Code: 368GB5141JClass: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
Code: 4GDQ854U53Class: ACTIBQuantity: 150 mg in 1 1
Code: LW2E03M5PGClass: ACTIBQuantity: 150 mg in 1 1
Code: G70B4ETF4SClass: ACTIBQuantity: 200 mg in 1 1
TenofovirActive
Code: FWF6Q91TZOClass: ACTIRQuantity: 10 mg in 1 1
HYDROXYPROPYL CELLULOSE (1600000 WAMW)Inactive
Code: RFW2ET671PClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
POLYVINYL ALCOHOL, UNSPECIFIEDInactive
Code: 532B59J990Class: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1AClass: IACT
FD&C BLUE NO. 2Inactive
Code: L06K8R7DQKClass: IACT
TALCInactive
Code: 7SEV7J4R1UClass: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRTClass: IACT
© Copyright 2025. All Rights Reserved by MedPath